Joseph Truitt
2017
In 2017, Joseph Truitt earned a total compensation of $1.1M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $122,582 |
|---|---|
| Option Awards | $539,351 |
| Salary | $389,971 |
| Other | $8,557 |
| Total | $1,060,461 |
Truitt received $539.4K in option awards, accounting for 51% of the total pay in 2017.
Truitt also received $122.6K in non-equity incentive plan, $390K in salary and $8.6K in other compensation.
Rankings
In 2017, Joseph Truitt's compensation ranked 8,710th out of 14,666 executives tracked by ExecPay. In other words, Truitt earned more than 40.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,710 out of 14,666 | 41st |
Division Manufacturing | 3,314 out of 5,768 | 43rd |
Major group Chemicals And Allied Products | 1,121 out of 2,074 | 46th |
Industry group Drugs | 891 out of 1,730 | 49th |
Industry Pharmaceutical Preparations | 698 out of 1,329 | 48th |
Source: SEC filing on April 15, 2019.
Truitt's colleagues
We found two more compensation records of executives who worked with Joseph Truitt at Achillion Pharmaceuticals in 2017.